Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
NCT00412789
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Interventions
DRUG:
Patupilone
Sponsor
Novartis Pharmaceuticals